Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN BSE: 537291 SECTOR: Agriculture  27k   109   10

189.40
-1.55 (-0.81%)
NSE: Today, 03:58 PM

Price Summary

Today's High

₹ 198

Today's Low

₹ 188

52 Week High

₹ 211.4

52 Week Low

₹ 128.85

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

359.94 Cr.

Enterprise Value

448.73 Cr.

No. of Shares

1.9 Cr.

P/E

10.24

P/B

0.62

Face Value

₹ 10

Div. Yield

1.03 %

Book Value (TTM)

₹  305.78

CASH

4.17 Cr.

DEBT

92.96 Cr.

Promoter Holding

45.6 %

EPS (TTM)

₹  18.5

Sales Growth

-9.49%

ROE

-11.66 %

ROCE

-7.82%

Profit Growth

-220.98 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-9.49%
3 Year6.43%
5 Year10.38%

Profit Growth

1 Year-220.98%
3 Year-220.55%
5 Year-232.83%

ROE%

1 Year-11.66%
3 Year2.44%
5 Year4.56%

ROCE %

1 Year-7.82%
3 Year3.73%
5 Year5.74%

Debt/Equity

0.1715

Price to Cash Flow

21.12

Interest Cover Ratio

-4.95524154907082

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 45.6 16.38
Dec 2022 45.6 16.38
Sep 2022 45.6 16.38
Jun 2022 41.07 9.34
Mar 2022 41.05 8.38
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -1503.75294377619 days.
  • Company has a healthy liquidity position with current ratio of 2.39073544404529.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.36254044908255.

 Limitations

  • The company has shown a poor profit growth of -220.554535661862% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.42509040509764% for the Past 3 years.
  • Company has a poor ROE of 2.44285889223984% over the past 3 years.
  • Company has a poor ROCE of 3.73488132212432% over the past 3 years
  • Company has low Interest coverage ratio of -4.95524154907082.
  • Tax rate is low at -6.23414486388247.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 27.21 209.39 21.73 25.3 44.92
Total Expenditure 48.47 174.91 16.98 19.68 40.83
Operating Profit -21.25 34.48 4.75 5.62 4.08
Other Income 0.73 0 0.2 0.06 0.26
Interest 2.47 2.88 2.75 2.96 1.53
Depreciation 1.05 0.67 0.67 0.67 0.99
Exceptional Items -88.78 0 0 0 0
Profit Before Tax -112.83 30.92 1.53 2.04 1.82
Tax 3.46 0.17 0.06 0.7 0.23
Profit After Tax -116.29 30.76 1.47 1.35 1.59
Adjusted EPS (Rs) -61.19 16.18 0.77 0.71 0.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 191.65 230.93 279.89 307.56 278.36
Total Expenditure 151.2 187.56 225.1 240.8 241.09
Operating Profit 40.45 43.37 54.79 66.76 37.27
Other Income 0.94 2.27 1.82 1.67 1.85
Interest 10.39 5.33 6.65 8.87 10.64
Depreciation 0.95 1.45 1.45 2.82 3.08
Exceptional Items 0 0 0 0 -88.78
Profit Before Tax 30.05 38.87 48.51 56.75 -63.39
Tax 0.64 0.43 -1.98 1.09 3.95
Net Profit 29.42 38.43 50.48 55.66 -67.34
Adjusted EPS (Rs.) 15.48 20.22 26.57 29.29 -35.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 19 19 19 19 19
Total Reserves 450.23 488.58 538.61 594.27 522.97
Borrowings 0.31 0.5 0.3 0.65 0.66
Other N/C liabilities 1.02 1.16 1.72 2.57 2.61
Current liabilities 99.79 138.68 169.62 173 196.66
Total Liabilities 570.34 647.93 729.25 789.51 741.91
Assets
Net Block 210.94 231.72 246.03 246.93 244.89
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5 5 5 5.05 5.06
Loans & Advances 0.18 1.43 5.89 1.44 21.79
Other N/C Assets 0.02 0.02 0 0 0
Current Assets 354.21 409.77 472.33 536.1 470.17
Total Assets 570.34 647.93 729.25 789.51 741.91
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 30.05 38.87 48.51 56.75 -63.39
Adjustment 10 4.56 6.99 9.79 101.38
Changes in Assets & Liabilities -87.16 -63.64 -44.5 -65.13 -18.07
Tax Paid 0.12 -2.72 -1.52 -0.3 -2.88
Operating Cash Flow -46.98 -22.94 9.48 1.11 17.05
Investing Cash Flow -4.07 -20.48 -14.44 -10.28 -19.87
Financing Cash Flow 89.87 20.14 5.56 16.4 -22.23
Net Cash Flow 38.81 -23.28 0.61 7.23 -25.05

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 41.05 41.07 45.60 45.60 45.60
ashu farms llp 10.99 10.99 10.99 10.99 10.99
akash farms llp 7.95 7.95 7.95 7.95 7.95
agri tech india li... 6.96 6.97 7.87 7.87 7.87
emerald seeds priv... - - 3.63 3.63 3.63
tingli finvest pvt... 2.96 2.96 2.96 2.96 2.96
nath royal ltd 2.60 2.60 2.60 2.60 2.60
nath industries li... 2.80 2.80 2.80 2.80 2.80
barkha farms priva... 1.86 1.86 1.86 1.86 1.86
ferry fax farms pr... 1.62 1.62 1.62 1.62 1.62
pithambar farms pr... 1.32 1.32 1.32 1.32 1.32
arati farms privat... 1.07 1.07 1.07 1.07 1.07
nath biotechnologi... 0.53 0.53 0.53 0.53 0.53
prabha farms priva... 0.40 0.40 0.40 0.40 0.40
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 58.95 58.93 54.40 54.40 54.40
authum investment ... 14.34 14.32 - - -
authum investment... - - - - -
aditya birla sun l... 4.84 - - 4.61 4.61
mayo farms llp - - 5.72 5.72 5.72
tapovan farms llp - - 5.18 5.18 5.18
aditya birlla sun ... - - 4.61 - -
indgrowth capital ... - - - - -
satpal khattar - 2.10 2.10 - 2.10
satpal khattar 2.10 - - - -
0 - - - 2.10 -
kbs properties pri... - - - 1.09 1.62
meghal bakulesh sh... 1.62 1.62 1.62 - -
bakulesh trambakla... - - - - -
bakulesh tramnakla... - - - - -
c mackertich priva... 1.01 - - - -
c makertich privat... - - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Nath Bio-Genes (India) informs about change in date of AGM and book closure 23 May 2023, 2:36PM Nath Bio-Genes - Quaterly Results22 Apr 2023, 5:58PM Nath Bio-Genes - Quaterly Results22 Apr 2023, 5:58PM Nath Bio-Genes (India) informs about compliance certificate17 Apr 2023, 2:36PM Nath Bio-Genes (India) informs about analyst meet6 Dec 2022, 3:17PM Nath Bio-Genes (India) informs about loss of share certificate 24 Nov 2022, 4:27PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes (India) informs about disclosure 3 Sep 2022, 11:20AM Nath Bio-Genes (India) informs about disclosure29 Aug 2022, 4:47PM Nath Bio-Genes (India) informs about compliance certificate27 Jul 2022, 11:58AM Nath Bio-Genes (India) informs about disclosure24 Jun 2022, 9:51AM Nath Bio-Genes - Quaterly Results11 Feb 2022, 4:17PM Nath Bio-Genes (India) board to approve financial results 4 Feb 2022, 5:09PM Nath Bio-Genes - Quaterly Results1 Nov 2021, 4:24PM Nath Bio-Genes (India) informs about board meeting25 Oct 2021, 12:58PM Nath Bio-Genes (India) informs about disclosure22 Jun 2021, 4:26PM Nath Bio-Genes (India) informs about compliance certificate’ 20 Apr 2021, 4:35PM Nath Bio-Genes (India) informs about presentation 12 Feb 2021, 10:36AM Nath Bio-Genes (India) to hold board meeting29 Oct 2020, 12:58PM Nath Bio-Genes (India) informs about virtual meeting22 Sep 2020, 10:47AM Nath Bio-Genes (India) informs about outcome of board meeting15 Jun 2020, 3:34PM Nath Bio-Genes introduces two new cotton hybrids in Indian market28 Apr 2020, 3:14PM

Nath Bio-Genes Stock Price Analysis and Quick Research Report. Is Nath Bio-Genes an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nath Bio-Genes has a PE ratio of 10.5058365758755 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nath Bio-Genes has ROA of -8.79420077453691 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nath Bio-Genes has a Current ratio of 2.39073544404529 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nath Bio-Genes has a ROE of -11.6577545846858 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Nath Bio-Genes has a D/E ratio of 0.1715 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Nath Bio-Genes has an Inventory turnover ratio of 1.24646523944083 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Nath Bio-Genes has reported revenue growth of -9.49365833325475 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Nath Bio-Genes for the current financial year is 13.388558723649 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nath Bio-Genes is Rs 2 and the yield is 1.0267 %.

Brief about Nath Bio-Genes

X